the limbus oncology UK

We're an independent news and education platform for clinical and medical oncologists in the UK.

[the limbus oncology UK @limbusoncUK]

REGISTER: https://t.co/pMcrJdy4gX
Join online as Dr Richard Berman and an expert panel share practical insights on supportive cancer care, focusing on the management of treatment related toxicities, pain, sexual health and more.

@AOlssonBrown @DanielMonnery @bermandr2

[the limbus oncology UK @limbusoncUK]

REGISTER: https://t.co/lbzCIT9fpf
Hear from an expert panel on the key developments in GI cancer over the past year. Topics include congress highlights, updated clinical guidelines & new drug approvals, with implications for UK practice. @Janetgr83596731 @MarcoGerlinger

[the limbus oncology UK @limbusoncUK]

Hundreds of thousands of retired staff will be forced to wait up to another 20 months
https://t.co/noDoeI91gN

[the limbus oncology UK @limbusoncUK]

One case involved a consultant who reported that a PA had “overruled” their request for a specific patient investigation
https://t.co/UkVzBr4Yxg

[the limbus oncology UK @limbusoncUK]

A man died after doctors misdiagnosed his glioblastoma as noncancerous – despite repeated scans showing it was malignant https://t.co/Wnzt8v14ga

[the limbus oncology UK @limbusoncUK]

A new £20 payment for GPs who seek specialist advice about referrals starts this month, but the number of requests they make can be capped to protect local NHS budgets https://t.co/QeKRgHdbVc

[the limbus oncology UK @limbusoncUK]

ON DEMAND: https://t.co/OEGZhLr7rv
Catch up as an expert panel of oncologists presents their selection of transformational clinical data from SABCS 2024 and discusses the impacts for clinical practice in the UK.

[the limbus oncology UK @limbusoncUK]

Sir Shankar Balasubramanian of @Cambridge_Uni and @CRUKCamCentre, Professor Caroline Dive of @CRUK_MI @CR_UK, and Professor Ian Workman of the Institute of Cancer Research have been made Fellows of the @AACR Academy.

https://t.co/hA6SdN9LD5

[the limbus oncology UK @limbusoncUK]

Using a diagnosis of advanced stage disease as an endpoint in cancer screening trials could reduce their size, duration and cost, thereby countering the UK’s “depressingly slow” rate of public health progress.

@petersasieni @CharlesSwanton

https://t.co/1EtNLOfnOa

[the limbus oncology UK @limbusoncUK]

Nearly 10,000 jobs are expected to be lost in the restructure, with savings of more than half a billion pounds a year redirected to doctors, nurses and frontline services
https://t.co/FmUdcV2xfJ

[the limbus oncology UK @limbusoncUK]

The removal of a requirement for a High Court judge to approve assisted dying applications will leave doctors “unduly exposed” if the bill becomes law - Medical Defence Union @the_mdu @MPS_Medical
https://t.co/B3FBDdIj2D

[the limbus oncology UK @limbusoncUK]

Clinicians taking biopsies from patients with suspected lung cancer should get them “right first time” to help cut genomic testing delays - @UKlungcancer report
https://t.co/zP9BdmbIKC

[the limbus oncology UK @limbusoncUK]

Most oncologists are women, mirroring a dominance of females in the medical workforce for the first time in the UK’s history
https://t.co/YD0OTRm99J

[the limbus oncology UK @limbusoncUK]

The GMC has clarified that no doctor can escape past fitness-to-practise issues by changing their gender - after suggesting the opposite to a national newspaper @gmcuk @Telegraph
https://t.co/IUY8Vb6S6J

[the limbus oncology UK @limbusoncUK]

Doctors whose careers are in jeopardy due to exam results botched by “human error” face an important deadline as medical bodies battle over what should happen to them
https://t.co/0XyThnEHx9

[the limbus oncology UK @limbusoncUK]

A coroner has warned that the NHS is compromising public safety by employing physician associates in roles outside their competency, after a woman died from a condition that a PA misdiagnosed as a nosebleed
https://t.co/DpizJaKL4O

[the limbus oncology UK @limbusoncUK]

Screening breast cancer survivors every 2 or 3 years, rather than annually, did not negatively impact breast cancer-specific survival, recurrence-free interval or overall survival.

https://t.co/9xBl8DokbU

[the limbus oncology UK @limbusoncUK]

The EDITH study will involve up to 700,000 women and will investigate whether an AI tool can replace one of the two human specialists currently required to assess mammogram images for signs of cancer.

https://t.co/2oQQ3VAifG

[the limbus oncology UK @limbusoncUK]

The retrospective study found that 86% of patients with advanced UGI tumours saw a complete or partial response, or achieved stable disease, after taking part in early stage research.

https://t.co/EQy1Ar3rOZ

[the limbus oncology UK @limbusoncUK]

“As a doctor it is heartbreaking to be unable to treat patients due to systemic issues"
https://t.co/WmPAOgWI92